Introduction
Fasting plasma tyrosine is raised in hyperthyroidism (Hall, Anderson and Smart, 1969) and serum magnesium levels are low in severe thyrotoxicosis (Marks and Ashraf, 1978) . Although tyrosine hydroxylase is the rate-limiting enzyme in the metabolism of tyrosine it is conceivable that more dihydroxyphenylalanine is formed under these conditions which may give rise to choreiform movements.
Two cases of chorea are described with responses and treatment. It is concluded that chorea is the severe end of the spectrum of dyskinesia of which tremor is the most common manifestation of milder thyrotoxicosis. It is also considered that chorea may be a commoner manifestation than previously Examination of the endocrine system showed smooth, firm enlargement of both lobes of the thyroid with a marked bruit.
The investigations of interest were an initially raised inorganic phosphate at 6 mg/100 ml and serum calcium at 12 mg/100 ml with alkaline phosphatase at 250 i.u./l. The 131I uptake was 84% of initial dose within 24 hr-(normal range 30-60% in 24 hr). Serum protein bound iodine was 14.9 mg/100 ml. Serum magnesium was 0.39 mmol/l (normal range, 0.7-1.0 mmol/l). 
Discussion
These are 2 cases that show chorea and choreoathetosis. The fact that the chorea responded to carbimazole treatment and did not recur, strongly implies that it was caused by the thyrotoxicosis and excessive secretion of thyroid hormones. It is suggested that the tremor of mild thyrotoxicosis is one end of a spectrum and choreo-athetosis represents the most severe form of inco-ordination. Jn cases of chorea described (Heffron and Eaton, 1970 ) the cessation of choreiform movement corresponded temporarily with the administration of antithyroid drugs and the resolution of the thyrotoxicosis. Treatment with propranolol produces resolution of the chorea within a matter of hours with no associated change in PBI or serum thyroxine. This observation suggests that the chorea is mediated by the sympathetic nervous system. The relationship between the sympathetic nervous system and thyrotoxicosis has been of interest since the observation of Goetsch (1918) that epinephrine exaggerated many of the signs and symptoms of thyrotoxicosis.
However, it has been found consistently that the concentration of circulating catecholamines is physiologically augmented by a surfeit of thyroid hormone. For this reason treatment with sympatholytic agents has constituted one therapeutic approach to thyrotoxicosis resulting in the use of reserpine, guanethidine, and propranolol most recently. The first 2 drugs deplete body stores of catecholamines and the third actually blocks the receptor. 
